Micronbrane Medical is a Taiwan-based startup that is innovating metagenomics through its genomic innovations. The company's focus is on developing technologies that enhance our understanding of microorganisms influencing human health and sustainability. Micronbrane Medical's proprietary technologies encompass special collection devices, novel host depletion, optimized reagents, advanced metagenomic sequencing assays, and rapid bioinformatic analysis software, resulting in a comprehensive solution for fast and accurate identification and monitoring of a broad range of microorganisms, such as bacteria, fungi, viruses, and parasites.Since its establishment in 2020, Micronbrane Medical has established partnerships and collaborations with leading academic institutions, health systems, and clinical laboratories globally, underscoring its commitment to transforming our interactions with the microbial world.
Specialized in Biotechnology, Health Care, Medical Devices, and Pharmaceutical industries, Micronbrane Medical presents an exciting opportunity for venture capital interested in the forefront of genomic and biotechnological advancements. For more information, visit micronbrane.com.
Taiwan
